Breaking News
Sort by:
Top Post
BioNTech Plans Malaria Vaccine Based on Revolutionary Covid-19 Jab Technology
BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the launch of its Malaria project, which aims to […]
Nightlife Industry Joins Covid-19 Vaccine Push for Young People
Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 Million Doses of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today […]
Healthcare Experts Say Long COVID Threat Means the Virus ‘Isn’t Done With Us Yet’
Medical experts fear long term fallout from being infected by COVID-19 could be even more […]
NHS COVID-19 App Updated to Notify Fewer Contacts to Isolate
The public is being urged to continue to use the NHS COVID-19 app as changes […]
New Tool for Early Identification of COVID-19 Surges
Health systems could use data from routine clinical care to identify the onset of upcoming […]
Theme Park Joins NHS Covid Vaccine Drive
Thorpe Park Resort will today (Thursday) join the roll-call of iconic locations to take part […]
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government […]
Chelsea and Westminster Launch Acute Covid App for NHS Staff
Acute Covid was developed as part of the CW Innovation programme, which has been fast-tracking […]
Vaxzevria is Highly Effective After One Dose Against Severe Disease or Hospitalisation Caused by Beta and Delta Variants of Concern
Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more